ZSCAN10
Basic information
Region (hg38): 16:3088890-3099295
Previous symbols: [ "ZNF206" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- ZSCAN10 Deficiency;Global developmental delay;Sensorineural hearing loss disorder (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZSCAN10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 50 | 58 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 2 | 0 | 50 | 10 | 4 |
Highest pathogenic variant AF is 0.00000657
Variants in ZSCAN10
This is a list of pathogenic ClinVar variants found in the ZSCAN10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-3089108-G-T | not specified | Uncertain significance (Mar 07, 2024) | ||
16-3089189-C-A | Likely benign (Feb 01, 2023) | |||
16-3089192-C-G | not specified | Uncertain significance (Oct 20, 2021) | ||
16-3089239-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
16-3089266-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
16-3089270-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
16-3089283-C-T | Likely benign (Mar 01, 2022) | |||
16-3089288-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
16-3089314-C-T | not specified | Uncertain significance (Jan 04, 2024) | ||
16-3089328-G-T | not specified | Uncertain significance (Jun 11, 2021) | ||
16-3089346-A-G | Likely benign (Mar 28, 2018) | |||
16-3089383-TG-T | Sensorineural hearing loss disorder;ZSCAN10 Deficiency;Global developmental delay • Otofacial neurodevelopmental syndrome | Pathogenic (Apr 05, 2022) | ||
16-3089389-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
16-3089511-C-G | not specified | Uncertain significance (Mar 01, 2023) | ||
16-3089551-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
16-3089617-T-G | not specified | Uncertain significance (Jun 07, 2023) | ||
16-3089624-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
16-3089764-C-T | not specified | Uncertain significance (Dec 16, 2022) | ||
16-3089792-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
16-3089803-T-G | not specified | Uncertain significance (May 08, 2023) | ||
16-3089839-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
16-3089867-C-T | not specified | Uncertain significance (Jun 17, 2022) | ||
16-3089878-C-T | not specified | Uncertain significance (May 17, 2023) | ||
16-3089903-C-T | not specified | Uncertain significance (Apr 28, 2023) | ||
16-3089933-C-A | not specified | Uncertain significance (Jan 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZSCAN10 | protein_coding | protein_coding | ENST00000252463 | 5 | 10428 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000804 | 0.997 | 125689 | 0 | 58 | 125747 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.506 | 456 | 487 | 0.935 | 0.0000370 | 4613 |
Missense in Polyphen | 186 | 214.2 | 0.86836 | 1999 | ||
Synonymous | -1.14 | 247 | 225 | 1.10 | 0.0000177 | 1514 |
Loss of Function | 2.57 | 11 | 24.9 | 0.443 | 0.00000123 | 248 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000987 | 0.0000906 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.0000574 | 0.0000544 |
Finnish | 0.00178 | 0.00176 |
European (Non-Finnish) | 0.000133 | 0.000123 |
Middle Eastern | 0.0000574 | 0.0000544 |
South Asian | 0.0000330 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Embryonic stem (ES) cell-specific transcription factor required to maintain ES cell pluripotency. Can both activate and /or repress expression of target genes, depending on the context. Specifically binds the 5'-[GA]CGCNNGCG[CT]-3' DNA consensus sequence. Regulates expression of POU5F1/OCT4, ZSCAN4 and ALYREF/THOC4. {ECO:0000250|UniProtKB:Q3URR7}.;
- Pathway
- Developmental Biology;Transcriptional regulation of pluripotent stem cells
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.490
- rvis_EVS
- -0.62
- rvis_percentile_EVS
- 17.36
Haploinsufficiency Scores
- pHI
- 0.480
- hipred
- N
- hipred_score
- 0.326
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.320
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zscan10
- Phenotype
- renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;somatic stem cell population maintenance;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding;metal ion binding